Joseph Ricotta, M.D., Medical Director of Vascular Surgery and Endovascular Therapy, Tenet Healthcare, Professor of Surgery, Charles E Schmidt College of Medicine, FAU comments on FDA clearance of CorPath GRX System in peripheral vascular interventions by Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics.
Tenet Florida Cardiovascular Care News
Dr. Joseph Ricotta, M.D. Comments on FDA Approval of CorPath GRX System
- Details